Company Overview - Xiangsheng Medical closed at 28.05 yuan, down 2.54%, with a rolling PE ratio of 21.94 times and a total market value of 3.145 billion yuan [1] - The company ranks 51st in the medical device industry, which has an average PE ratio of 45.94 times and a median of 29.64 times [1] Institutional Holdings - As of the Q3 2024 report, 56 institutions hold shares in Xiangsheng Medical, with a total of 3.6195 million shares valued at 0.088 billion yuan [1] Business Operations - Xiangsheng Medical specializes in the research, development, manufacturing, and sales of ultrasound medical imaging equipment, including portable color ultrasound, trolley ultrasound, and black-and-white ultrasound [1] - The company's products are used in over 30% of tertiary hospitals in China, including renowned institutions like Peking Union Medical College Hospital and West China Hospital of Sichuan University [1] - The company also leads in service evaluations among domestic grassroots medical institutions [1] Financial Performance - For Q3 2024, Xiangsheng Medical reported revenue of 362 million yuan, a year-on-year decrease of 9.85%, and a net profit of 98.4086 million yuan, down 30.42% year-on-year, with a gross profit margin of 59.15% [1]
祥生医疗收盘下跌2.54%,滚动市盈率21.94倍,总市值31.45亿元